Cristina Marco Noain

Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez.

Sociedad de Desarrollo de Navarra SL (Sociedad de Desarrollo de Navarra) is a private equity and venture capital arm of Corporación Pública Empresarial de Navarra SLU founded in 1984. The firm is headquartered in Pamplona, Spain.